CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy.
Pant A, Hwa-Lin Bergsneider B, Srivastava S, Kim T, Jain A, Bom S, Shah P, Kannapadi N, Patel K, Choi J, Cho KB, Verma R, Yu-Ju Wu C, Brem H, Tyler B, Pardoll DM, Jackson C, Lim M.
Pant A, et al. Among authors: bom s.
Oncoimmunology. 2024 Apr 4;13(1):2338965. doi: 10.1080/2162402X.2024.2338965. eCollection 2024.
Oncoimmunology. 2024.
PMID: 38590799
Free PMC article.